COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN THE UNITED KINGDOM

被引：0
|
作者：
Betts, K. A. [1 ]
Sundaram, M. [2 ]
Mughal, F. [3 ]
Yan, S. Y. [1 ]
Signorovitch, J. [1 ]
Wang, K. [2 ]
Wu, E. Q. [1 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] AbbVie Inc, N Chicago, IL USA
[3] AbbVie Ltd, Maidenhead, Berks, England
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1163
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A505 / A506
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GERMANY
    Betts, K.
    Yan, Y.
    Sundaram, M.
    Hengst, N.
    Wolff, M.
    Bensimon, A. G.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A570 - A570
  • [2] COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS FOR MODERATE TO SEVERE PSORIASIS
    Carretero, G.
    Moreno, J. C.
    Notario, J.
    Silvestre, J. F.
    Lopez-Belmonte, J. L.
    Gimenez, E.
    Sabater, F. J.
    Fonseca, E.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A457 - A457
  • [3] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
    Wu, Jashin J.
    Feldman, Steven R.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 769 - 774
  • [4] A COST-EFFECTIVENESS ANALYSIS OF COMMONLY USED BIOLOGIC DRUGS FOR THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE UNITED STATES
    Wu, J. J.
    Feldman, S. R.
    Rastogi, S.
    Menges, B.
    Lingohr-Smith, M.
    Lin, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S240 - S240
  • [5] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment
    Wu, Jashin J.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB83 - AB83
  • [6] Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
    Jia, Xiaoying
    Zhao, Yang
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Mendelsohn, Alan M.
    Lowry, Simon
    Feldman, Steve
    Wu, Jashin J.
    Armstrong, April W.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 740 - 748
  • [7] Comparative cost-effectiveness for tildrakizumab and other targeted therapies for the treatment of moderate to severe plaque psoriasis in the United States
    Jia, Xiaoying
    Mendelsohn, Alan
    Zhang, Jingchuan
    Carrico, Justin
    Brodtkorb, Thor-Henrik
    Zhao, Yang
    Feldman, Steven
    Armstrong, April
    Wu, Jashin J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB80 - AB80
  • [8] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [9] A cost-effectiveness analysis of biologic therapies for the treatment of chronic plaque psoriasis
    Roberts, G.
    Morris, J.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A267 - A267
  • [10] COST-EFFECTIVENESS OF SEQUENCES OF BIOLOGIC TREATMENTS FOR MODERATE-TO-SEVERE PSORIASIS IN FINLAND
    Asseburg, C.
    Valgardsson, S.
    Soini, E. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A507 - A508
12345